https://doi.org/10.4081/monaldi.2008.402
Does 18F-fluorodeoxyglucose PET/CT have a role in the management of pulmonary and extra pulmonary sarcoidosis?
Submitted: January 26, 2016
Accepted: January 26, 2016
Published: January 26, 2016
Accepted: January 26, 2016
Abstract Views: 448
PDF: 343
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
How to Cite
Carbone, R., A. Douroukas, V. Arena, D. Cantalupi, E. Balleari, R. Ghio, and E. Pelosi. 2016. “Does 18F-Fluorodeoxyglucose PET/CT Have a Role in the Management of Pulmonary and Extra Pulmonary Sarcoidosis?”. Monaldi Archives for Chest Disease 69 (2). https://doi.org/10.4081/monaldi.2008.402.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
